Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • KKR to infuse Rs 2000...

    KKR to infuse Rs 2000 crore in Emami Group

    GarimaWritten by Garima Published On 2019-02-17T10:00:27+05:30  |  Updated On 17 Feb 2019 10:00 AM IST
    KKR to infuse Rs 2000 crore in Emami Group

    Mumbai: Headquartered in Kolkata, the Emami Group is all set to get fresh funds for its trade as the firm is in advanced negotiations with US private equity firm KKR for a structured credit deal worth Rs 2,000 crore.


    The money is going to come in the form of debt by KKR and Emami may use the money extended to repay the loans raised by promoters and to meet working capital requirements, suggests recent media reports.


    The inception of Emami Group took place in the mid-1970s when two childhood friends, R S Agarwal and R S Goenka, left their management jobs with the Birla Group to set up Kemco Chemicals, Ayurvedic medicine and cosmetic manufacturing unit in Kolkata in 1974. At that time the Indian FMCG market was still dominated by multinationals.


    The company was established with a modest capital of Rs. 20,000 and started manufacturing cosmetic products as well as Ayurvedic medicines under the brand name of Emami from a small factory in Kolkata, targeting sales at the Indian middle class. Today, Emami owns businesses in sectors ranging from consumer goods to healthcare, cement, newsprint, biodiesel and edible oil, real estate, solar power, writing instruments and pharmacy retail.


    Also Read: Emami acquires German brand Creme 21 for Rs 100 crore



    Over the years, Emami has seen significant expansion in different sectors. In the past 10 years, it has reportedly acquired 10 companies or brands including heavy investment in the cement sector. The group acquired Eco-Cement in Bihar and had also invested Rs 4,000 crore in three greenfield cement plants.


    Presently, it is learnt via the ongoing negotiation that KKR will help Emami expand its cement business and retain focus on consumer goods and cement, people aware of the matter told
    money control.

    Accordingly to the daily, to finance part of this, the promoters have pledged shares in one of the most successfully run business – the FMCG business of Emami. It’s noteworthy that Emami’s profitability is one of the highest in the FMCG sector.


    KKR may earn interest that is expected to be charged in the range of 12-15 per cent secured by the group's cement and property business.


    Also Read: KKR in Advanced talks to acquire SRL Diagnostics

    acquireCement businesscompaniesDaburEmamiEmami GroupequityFMCGhealth news in indiaHULinvestment newsinvestment news in indiaKKRNew York Citypersonal carepersonal care brand in indiapledgePrivate equityreal estaterecommendations
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Garima
    Garima

      Garima joined Medical Dialogues in the year 2017 and is currently working as a Senior Editor. She looks after all the Healthcare news pertaining to Medico-legal cases, MCI/DCI decisions, Medical Education issues, government policies as well as all the news and updates concerning Medical and Dental Colleges in India. She is a graduate from Delhi University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok